Arkolith/Insider Trading/PCRX/Form 4

Cross Shawn

Chief Financial OfficerPacira BioSciences, Inc. (PCRX) · full profile →Form 4 · filed Dec 11, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$627K
Net Open-Market Flow
-$627K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 10, 2025Option exercise(M)9K$16.45$150K65K
Dec 10, 2025Sell(S)9K$25.14$229K56K
Dec 9, 2025Option exercise(M)16K$16.45$261K72K
Dec 9, 2025Sell(S)16K$25.03$398K56K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 10, 2025Option exercise(M)9K—$0175K
Dec 9, 2025Option exercise(M)16K—$0184K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-25-056645) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML